Long QT syndrome and epilepsy: when diagnoses overlap

A collapse with jerking movements is often labelled a seizure before the heart has been assessed. Yet ventricular arrhythmias, particularly torsades de pointes in long QT syndrome (LQTS), can briefly reduce cerebral blood flow and produce loss of consciousness, stiffening, and limb movements that closely resemble epilepsy. The distinction matters because the treatment pathways are fundamentally different.

LQTS is an inherited or acquired disorder of cardiac repolarisation. It may arise from pathogenic variants affecting cardiac ion channels, or from medicines, electrolyte disturbances, and systemic illness. Epilepsy, by contrast, reflects a tendency to recurrent unprovoked seizures caused by abnormal electrical activity in the brain. A person can have both conditions, but a seizure-like event does not establish a neurological diagnosis.

This diagnostic overlap is particularly important in younger people with unexplained syncope, a family history of sudden death, or episodes triggered by exercise, fright, or sudden noise. In Australia, a patient may first present to an emergency department in Melbourne, a regional hospital in Queensland, or a general practice in Perth, where access to electrophysiology and video-EEG services differs considerably.

A careful history, 12-lead electrocardiogram, medication review, and coordinated assessment can prevent years of diagnostic uncertainty. The aim is not to choose cardiology over neurology, but to identify the mechanism of the event and protect the patient from avoidable sudden cardiac death or inappropriate treatment.

Why cardiac syncope can look like a seizure

During torsades de pointes or another malignant ventricular tachyarrhythmia, cardiac output can fall abruptly. The brain becomes temporarily underperfused, causing sudden loss of consciousness. Brief tonic stiffening, irregular jerks, eye deviation, or urinary incontinence may follow. These features are not exclusive to epilepsy and can mislead witnesses and clinicians.

The pattern of recovery often provides a useful clue. Arrhythmic syncope typically begins without a prolonged warning, lasts for a short period, and is followed by relatively rapid orientation once circulation returns. A person with a generalised epileptic seizure may have a longer postictal phase, marked confusion, headache, muscle soreness, or profound fatigue. These distinctions are helpful rather than absolute, particularly when the event was unwitnessed.

Palpitations immediately before collapse, syncope during swimming or exertion, episodes after a sudden alarm, and a family history of unexplained drowning or sudden death should heighten suspicion of LQTS. A normal neurological examination between events does not exclude epilepsy, just as a normal initial ECG does not completely exclude an intermittent cardiac disorder.

Reading the QT interval in context

The corrected QT interval, or QTc, estimates ventricular repolarisation while accounting for heart rate. Bazett’s formula is widely used but can overcorrect at faster rates and undercorrect at slower rates. Fridericia correction and manual review may be valuable when the ECG is borderline, the rhythm is irregular, or the automated measurement appears implausible.

A prolonged QTc supports the diagnosis but should not be interpreted in isolation. The measurement can vary with autonomic tone, electrolyte levels, medications, illness, and technical factors. Serial ECGs are often more informative than a single tracing. Clinicians should inspect the T-wave shape, look for beat-to-beat variation, and consider whether the tracing was recorded after a collapse or during treatment.

Diagnostic scoring systems, exercise testing, ambulatory monitoring, and genetic testing may help identify congenital LQTS. A pathogenic variant can support a diagnosis even when the QTc is not dramatically prolonged, but a negative genetic test does not rule it out. Family screening is important when the clinical picture suggests an inherited syndrome.

Medicines and reversible contributors

Many drugs can lengthen ventricular repolarisation or increase the risk of torsades de pointes. Some antiarrhythmics are well recognised, while other contributors include selected antimicrobials, antipsychotics, antidepressants, antiemetics, and medicines used in specialist settings. Risk rises when several QT-prolonging agents are combined or when kidney or liver dysfunction increases drug exposure.

Electrolyte abnormalities deserve prompt attention. Low potassium, magnesium, or calcium may convert a borderline QT into a dangerous substrate, especially during vomiting, diarrhoea, fasting, or acute illness. In Australia, pharmacists, emergency clinicians, and general practitioners can use reputable medication-safety resources to check interactions and identify alternatives. Patients should not stop prescribed treatment abruptly without clinical advice, particularly antiseizure medicines or antiarrhythmics.

Acquired QT prolongation can mimic an inherited syndrome, while congenital susceptibility may be unmasked by a commonly prescribed medicine. The practical response is a complete medication and supplement history, repeat ECG after reversible factors are corrected, and communication between the treating team and the patient’s regular doctor.

When epilepsy treatment does not solve the problem

A person may be diagnosed with epilepsy after one convulsive episode and then receive antiseizure therapy for years. If the true mechanism is arrhythmic syncope, episodes may continue because the underlying electrical instability has not been addressed. Some antiseizure medicines may also affect cardiac conduction or repolarisation, making specialist review important when the ECG is abnormal.

The reverse problem also occurs. A patient with genuine epilepsy may have an incidental prolonged QTc caused by medication, electrolyte imbalance, or an inherited channelopathy. Cardiac findings should therefore be assessed rather than dismissed as a by-product of a neurological diagnosis. A normal routine EEG does not exclude epilepsy, and an abnormal ECG does not prove that every collapse is cardiac.

Long-term video-EEG monitoring can capture brain activity during an event, while ambulatory ECG, implantable loop recording, exercise testing, or provocation protocols can investigate intermittent arrhythmia. These tests answer different questions. A multidisciplinary service involving an epileptologist, cardiologist, genetic counsellor, and electrophysiologist is often the safest route when the history remains unclear.

Shared biology and channel disorders

Some genetic conditions affect ion channels expressed in both the myocardium and the nervous system. The relationship is complex: a variant may produce a primary cardiac phenotype, a neurological phenotype, or variable manifestations among relatives. This helps explain why a patient with suspected LQTS may also report seizures, developmental concerns, or a family history of epilepsy.

KCNQ1, KCNH2, and SCN5A are among the genes associated with inherited arrhythmia syndromes, although genotype–phenotype relationships are not uniform. Certain variants and overlapping channelopathies can create diagnostic uncertainty. Genetic findings should be interpreted with phenotype, family history, and laboratory classification rather than treated as a standalone answer.

When a clinically important variant is identified, cascade testing may allow relatives to receive ECG assessment before symptoms occur. This has particular value in dispersed Australian families, including those living far from tertiary centres. Telehealth can support follow-up, but an ECG, medication review, and emergency plan still require appropriate local services.

Practical assessment across Australian care settings

The first assessment should document the circumstances of the event: posture, exertion, emotional trigger, prodrome, colour change, movements, duration, injury, recovery, and witness observations. Ask specifically about swimming, loud noises, sleep, fever, vomiting, new medicines, and recreational substances. A family history should include sudden unexplained death, drowning, “seizures,” fainting, implanted defibrillators, and deaths before the age of 40.

For patients in Sydney, Brisbane, or Adelaide, referral to a cardiac electrophysiology service may be relatively straightforward, although waiting times and public–private pathways vary. In regional Western Australia, the Northern Territory, or rural New South Wales, ECG review and specialist advice may require coordinated retrieval, outreach, or telehealth. The patient should leave with clear instructions about warning symptoms and when to seek emergency care through 000.

Driving and occupational advice must follow Australian state and territory rules, which may differ depending on whether the event is classified as syncope, seizure, or a confirmed arrhythmia. Clinicians should document the working diagnosis and reassess it as evidence develops. Patients should also be counselled about strenuous exercise, swimming alone, overheating, dehydration, and medicines that may prolong QT.

Treatment for congenital LQTS can include lifestyle measures, beta-blockers, left cardiac sympathetic denervation, or an implantable cardioverter-defibrillator in selected high-risk patients. Management depends on genotype, symptoms, QTc, family history, and response to therapy. For an overview of developments in procedural safety and outcomes, readers can examine catheter ablation complications, while remembering that ablation is not the standard treatment for congenital LQTS itself.

Building a safer diagnostic pathway

A robust pathway begins with treating a seizure-like collapse as an undifferentiated transient loss of consciousness until evidence supports a specific cause. The initial ECG should be reviewed by someone experienced in QT measurement, not merely accepted from an automated report. Electrolytes, glucose, renal function, medication exposure, and signs of structural heart disease should be assessed according to the clinical context.

If congenital LQTS is suspected, relatives may need ECGs and genetic counselling. If epilepsy remains plausible, neurological assessment and EEG should proceed in parallel rather than waiting for repeated events. Witness videos, where safely obtained, can be highly informative. Patients should be encouraged to bring discharge summaries and medicine lists to every appointment.

Clinicians and researchers can follow the evolving evidence through the journal’s arrhythmia article collection, including work on inherited arrhythmia, sudden death prevention, devices, and electrophysiology. Authors contributing new data should also review the journal’s author guidelines before preparing a manuscript, particularly when reporting genetic cohorts, diagnostic pathways, or outcomes across health systems.

Recognising the overlap between LQTS and epilepsy protects patients from two kinds of harm: missed cardiac risk and unnecessary neurological labelling. A structured history, repeated ECG assessment, medication vigilance, family evaluation, and collaboration across specialties can turn an apparently confusing collapse into a treatable diagnosis. Share clear emergency plans with patients and relatives, document the reasoning behind the diagnosis, and refer promptly when inherited arrhythmia is possible.